Theravance Biopharma Board Member Sells 274K Shares Amid Post-Acquisition Transition
Theravance insider selling continues—Samaha Eli sells 273,871 shares at $17.23—reflects routine liquidity amid Zymeworks acquisition, not panic.
3 minutes to read
THERAVANCE BIOPHARMA INC
Theravance Insider Trades: SVP Rhonda Farnum Sells 13,314 Shares as Directors Buy Fresh Blocks – No Red Flags Yet.
Theravance insider trading: SVP Rhonda Farnum sells 13,314 shares at $16.39, amid a 57% YTD rally and a 52‑week high—routine liquidity, not a red flag.
3 minutes to read
Theravance CEO and Execs Snap Up 75,000 Shares Amid Price Slump and Shareholder‑Rights Probe—Are They Betting on a Rebound?
Theravance insider buying sparks debate: CEO and execs snap up shares amid share slump and a pending shareholder‑rights case, hinting at potential upside yet raising caution for investors.
3 minutes to read
Theravance CEO Sells 75,000 Shares in Tax‑Planning Move Amid Surge in Social‑Media Buzz and Negative Sentiment
Theravance CEO sells 75k shares for tax planning: insider moves, market sentiment, and long‑term growth prospects explained.
4 minutes to read